Glen Eagle Advisors, LLC Becton Dickinson & CO Transaction History

Glen Eagle Advisors, LLC

  • $546 Billion
  • Q2 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 1,248 shares of BDX stock, worth $290,297. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,248
Previous 633 97.16%
Holding current value
$290,297
Previous $137 Million 112.61%
% of portfolio
0.05%
Previous 0.11%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$225.07 - $246.17 $138,418 - $151,394
615 Added 97.16%
1,248 $292 Million
Q1 2024

Jul 03, 2024
BUY
$233.45 - $247.73 $291,112 - $308,919
1,247 New
1,247 $309 Million
Q3 2023

Aug 13, 2024
BUY
$254.9 - $283.59 $4,843 - $5,388
19 Added 1.72%
1,124 $291 Million
Q2 2023

Aug 13, 2024
BUY
$238.39 - $265.32 $15,495 - $17,245
65 Added 6.25%
1,105 $292 Million
Q1 2023

Aug 13, 2024
BUY
$229.71 - $259.35 $229 - $259
1 Added 0.1%
1,040 $257 Million
Q4 2022

Aug 13, 2024
BUY
$218.29 - $256.91 $654 - $770
3 Added 0.29%
1,039 $264 Million
Q3 2022

Aug 13, 2024
BUY
$51.03 - $264.23 $255 - $1,321
5 Added 0.48%
1,036 $231 Million
Q2 2022

Aug 13, 2024
BUY
$234.74 - $275.42 $42,018 - $49,300
179 Added 21.01%
1,031 $254 Million
Q4 2021

Aug 13, 2024
BUY
$230.08 - $250.94 $2,300 - $2,509
10 Added 1.19%
852 $214 Million
Q3 2021

Aug 13, 2024
BUY
$232.72 - $256.47 $232 - $256
1 Added 0.12%
842 $207 Million
Q2 2021

Aug 13, 2024
BUY
$232.65 - $254.58 $6,048 - $6,619
26 Added 3.19%
841 $205 Million
Q4 2020

Aug 13, 2024
SELL
$221.92 - $245.94 $95,869 - $106,246
-432 Reduced 34.64%
815 $204 Million
Q3 2020

Aug 13, 2024
SELL
$215.77 - $276.76 $30,207 - $38,746
-140 Reduced 14.66%
815 $190 Million
Q2 2020

Aug 13, 2024
BUY
$219.9 - $263.41 $1,319 - $1,580
6 Added 0.63%
955 $229 Million
Q1 2020

Aug 13, 2024
BUY
$195.69 - $279.01 $17,612 - $25,110
90 Added 10.48%
949 $218 Million
Q4 2019

Aug 13, 2024
BUY
$236.45 - $266.82 $53,437 - $60,301
226 Added 35.7%
859 $234 Million
Q1 2019

Aug 13, 2024
SELL
$206.05 - $248.17 $126,514 - $152,376
-614 Reduced 49.24%
633 $158 Million
Q1 2018

Aug 14, 2024
SELL
$205.46 - $240.27 $126,152 - $147,525
-614 Reduced 49.24%
633 $137 Million
Q1 2018

Aug 13, 2024
BUY
$205.46 - $240.27 $20,546 - $24,027
100 Added 18.76%
633 $137 Million
Q3 2017

Aug 13, 2024
SELL
$186.89 - $198.9 $133,439 - $142,014
-714 Reduced 57.26%
533 $104 Million
Q2 2017

Aug 12, 2024
SELL
N/A
-9 Reduced 1.62%
545 $106 Million
Q4 2016

Aug 12, 2024
SELL
N/A
-693
554 $91.7 Million

Others Institutions Holding BDX

# of Institutions
1,734
Shares Held
252M
Call Options Held
586K
Put Options Held
649K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email